Home / Lisdexamfetamine / United States
US ATC N06BA12 · updated 2 Nov 2026
Lisdexamfetamine shortage in United States
Is there a Lisdexamfetamine shortage in United States?
Yes. As of 2 Nov 2026, 108 Lisdexamfetamine products are reported short in United States, the first since 14 Jul 2023. No return date has been given. Main reason: not stated.
Also short in Spain, Austria, Norway, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) limited | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) limited | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) limited | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) limited | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | Rhodes Pharmaceuticals L.P. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) limited | Hikma Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Mylan Pharmaceuticals Inc., a Viatris Company | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Teva Pharmaceuticals USA, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) limited | Solco Healthcare US, LLC | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Alvogen | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) limited | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) limited | Elite Laboratories, Inc. | 14 Jul 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) | Amneal Pharmaceuticals | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Sun Pharmaceutical Industries, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Novadoz Pharmaceuticals LLC | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Takeda Pharmaceuticals USA Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Lannett Company, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) limited | Lannett Company, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) limited | Lannett Company, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) limited | Lannett Company, Inc. | 14 Jul 2023 | not given | Other |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Lannett Company, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | SpecGx LLC | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Lannett Company, Inc. | 14 Jul 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Lannett Company, Inc. | 20 Sep 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Apotex Corp. | 1 Nov 2023 | not given | Not stated |
| US | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) limited | Rhodes Pharmaceuticals L.P. | 11 Jan 2024 | not given | Active ingredient shortage Shortage of an active ingredient |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).